AbbVie Inc.
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Botox Therapeutic (onabotulinumtoxinA) by Year
Botox Therapeutic (onabotulinumtoxinA) — Worldwide operational (constant-currency) growth YoY (%) (%)
AbbVie Botox Therapeutic (onabotulinumtoxinA): 14.9% in FY2025, up 4.4 pts from a year earlier.
Where the FY2025 figure comes from
“|| Botox Therapeutic | 3,151 | 618 | 3,769 | 16.0 | 9.3 | 14.8 | 9.9 | 14.9”
Source: Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
Reported in Form 8-K Key Product Revenues Schedule.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Botox Therapeutic (onabotulinumtoxinA) — Worldwide operational (constant-currency) growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.9% | +4.4 pts | Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 10.5% | -0.3 pts | Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗ |
| FY2023 | Dec 31, 2023 | 10.8% | -1.8 pts | Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗ |
| FY2022 | Dec 31, 2022 | 12.6% | – | Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗ |
Cite this data
StockData. (2026). AbbVie Botox Therapeutic (onabotulinumtoxinA) (%), annual FY2022–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/botox-ther-ww-op-yoy
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.